Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status
The IMID Forum
00:00
Longer-Term Safety Analysis of New Drug Treatment
Discussion on the absence of new safety signals in a well-designed cohort study for a new drug treatment, highlighting the importance of analyzing efficacy and safety results, and considering both positive and negative outcomes in treatment studies.
Transcript
Play full episode
